Cobertura de vacunación contra COVID-19 por esquema en Colombia

Autores:: Díaz Pinzón, Jorge Enrique

Tipo de recurso:: Article of journal

Fecha de publicación:: 2021

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_723e9c99b4d3d74d1ac87d6b909b60f1
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/3084
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Cobertura de vacunación contra COVID-19 por esquema en Colombia
dc.title.translated.eng.fl_str_mv	COVID-19 vaccination coverage by regime in Colombia
title	Cobertura de vacunación contra COVID-19 por esquema en Colombia
spellingShingle	Cobertura de vacunación contra COVID-19 por esquema en Colombia COVID-19 SARS-COV-2 pandemia vacunas COVID-19 SARS-COV-2 pandemic vaccines
title_short	Cobertura de vacunación contra COVID-19 por esquema en Colombia
title_full	Cobertura de vacunación contra COVID-19 por esquema en Colombia
title_fullStr	Cobertura de vacunación contra COVID-19 por esquema en Colombia
title_full_unstemmed	Cobertura de vacunación contra COVID-19 por esquema en Colombia
title_sort	Cobertura de vacunación contra COVID-19 por esquema en Colombia
dc.creator.fl_str_mv	Díaz Pinzón, Jorge Enrique
dc.contributor.author.spa.fl_str_mv	Díaz Pinzón, Jorge Enrique
dc.subject.spa.fl_str_mv	COVID-19 SARS-COV-2 pandemia vacunas
topic	COVID-19 SARS-COV-2 pandemia vacunas COVID-19 SARS-COV-2 pandemic vaccines
dc.subject.eng.fl_str_mv	COVID-19 SARS-COV-2 pandemic vaccines
publishDate	2021
dc.date.accessioned.none.fl_str_mv	2021-03-08 00:00:00 2022-06-29T19:39:37Z
dc.date.issued.none.fl_str_mv	2021-03-08
dc.date.available.none.fl_str_mv	2021-03-08 00:00:00 2022-06-29T19:39:37Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.01217372.1280
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/3084
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.01217372.1280
identifier_str_mv	10.31260/RepertMedCir.01217372.1280 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/3084 https://doi.org/10.31260/RepertMedCir.01217372.1280
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Jiang S, Bottazzi ME, Du L, Lustigman S, Tseng CT, Curti E, et al. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Rev Vaccines. 2012;11(12):1405–13. https://doi.org/10.1586/erv.12.126 2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 3. Chen WH, Strych U, Hotez PJ, Bottazzi ME. El proceso de vacunación contra el SARS-CoV-2: una descripción general. Curr Trop Med Rep. 2020;1-4. https://doi.org/10.1007/s40475-020-00201-6 4. Thepharmaletter. J&J working on coronavirus vaccine [Internet]. Thepharmaletter; 2020 [citado julio de 2021]. Disponible en: https://www.thepharmaletter.com/article/j-j-working-on-coronavirus-vaccine 5. Cheung E. China coronavirus: Hong Kong researchers have already developed vaccine but need time to test it, expert reveals [Internet]. South China Morning Post; 2020 [citado julio de 2021]. Disponible en: https://www.scmp.com/comment/opinion/article/3150152/china-joining-pacific-trade-pact-would-benefit-all-members-gaining?module=perpetual_scroll&pgtype=article&campaign=3150152 Shieber J. Codagenix raises $20 million for a new flu vaccine and other therapies [Internet]. Join TechCrunch; 2020 [citado julio de 2021]. Disponible en: https://techcrunch.com/2020/01/13/codagenix-raises-20-million-for-a-new-flu-vaccine-and-other-therapies/ 7. Chen WH, Chag SM, Poongavanam MV, Biter AB, Ewere EA, Rezende W, et al. Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. J Pharm Sci. 2017;106(8):1961–1970. https://doi.org/10.1016/j.xphs.2017.04.037 8. Biofarmacéuticos Clover. Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV) [Internet]. 2020 [citado julio de 2021]. Disponible en: https://pipelinereview.com/index.php/2020012873644/Vaccines/Clover-Initiates-Development-of-Recombinant-Subunit-Trimer-Vaccine-for-Wuhan-Coronavirus-2019-nCoV.html 9. Janssen Vaccines & Prevention B.V. A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants [Internet]. ClinicalTrials.gov; 2017 [citado julio de 2021]. Disponible en: https://clinicaltrials.gov/ct2/show/NCT02543567 Chen WH, Du L, Chag SM, Ma C, Tricoche N, Tao X, et al. Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Hum Vaccin Immunother. 2014;10(3):648-58. doi: 10.4161/hv.27464 11. Coleman CM, Liu YV, Mu H, Taylor JK, Massare M, Flyer DC, et al. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014;32(26):3169–74. https://doi.org/10.1016/j.vaccine.2014.04.016 12. Ministerio de Salud y Protección Social de Colombia. Plan de vacunación nacional contra COVID-19 [Internet]. 2021. Disponible en: https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx Díaz Pinzón JE. Estimación de la prevalencia del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):99–102. https://doi.org/10.31260/RepertMedCir.01217372.1115 Díaz Pinzón JE. Análisis de los resultados del contagio del COVID-19 respecto a su distribución geográfica en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):60–64. https://doi.org/10.31260/RepertMedCir.01217372.1082 Díaz Pinzón JE. Dinámica y relación del contagio del COVID-19 después de iniciado el plan de vacunación contra el SARS-COV-2 en Colombia. Repert Med Cir. 2021;30(Núm. Supl.1):41–45. https://doi.org/10.31260/RepertMedCir.01217372.1227
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1750 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1751 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1752 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1767 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1753
dc.relation.citationedition.spa.fl_str_mv	: Vol. 30 Suplemento 2021
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía - 2021
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Revista Repertorio de Medicina y Cirugía - 2021 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf text/html application/epub+zip text/xml audio/mpeg
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1280
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/e5a95254-6995-4d6f-b9a1-390d5aef280a/download
bitstream.checksum.fl_str_mv	a0cddd0c99eaecf4ba717f11759abf4f
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1811575329309851648
spelling	Díaz Pinzón, Jorge Enriquee068261d2a3332b52a99839e09374e185002021-03-08 00:00:002022-06-29T19:39:37Z2021-03-082021-03-08 00:00:002022-06-29T19:39:37ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludRevista Repertorio de Medicina y Cirugía - 2021info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1280COVID-19SARS-COV-2pandemiavacunasCOVID-19SARS-COV-2pandemicvaccinesCobertura de vacunación contra COVID-19 por esquema en ColombiaCOVID-19 vaccination coverage by regime in Colombiaapplication/pdftext/htmlapplication/epub+ziptext/xmlaudio/mpegArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.01217372.12800121-7372https://repositorio.fucsalud.edu.co/handle/001/30842462-991Xhttps://doi.org/10.31260/RepertMedCir.01217372.1280spaJiang S, Bottazzi ME, Du L, Lustigman S, Tseng CT, Curti E, et al. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Rev Vaccines. 2012;11(12):1405–13. https://doi.org/10.1586/erv.12.126 2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 3. Chen WH, Strych U, Hotez PJ, Bottazzi ME. El proceso de vacunación contra el SARS-CoV-2: una descripción general. Curr Trop Med Rep. 2020;1-4. https://doi.org/10.1007/s40475-020-00201-6 4. Thepharmaletter. J&J working on coronavirus vaccine [Internet]. Thepharmaletter; 2020 [citado julio de 2021]. Disponible en: https://www.thepharmaletter.com/article/j-j-working-on-coronavirus-vaccine 5. Cheung E. China coronavirus: Hong Kong researchers have already developed vaccine but need time to test it, expert reveals [Internet]. South China Morning Post; 2020 [citado julio de 2021]. Disponible en: https://www.scmp.com/comment/opinion/article/3150152/china-joining-pacific-trade-pact-would-benefit-all-members-gaining?module=perpetual_scroll&pgtype=article&campaign=3150152Shieber J. Codagenix raises $20 million for a new flu vaccine and other therapies [Internet]. Join TechCrunch; 2020 [citado julio de 2021]. Disponible en: https://techcrunch.com/2020/01/13/codagenix-raises-20-million-for-a-new-flu-vaccine-and-other-therapies/ 7. Chen WH, Chag SM, Poongavanam MV, Biter AB, Ewere EA, Rezende W, et al. Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. J Pharm Sci. 2017;106(8):1961–1970. https://doi.org/10.1016/j.xphs.2017.04.037 8. Biofarmacéuticos Clover. Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV) [Internet]. 2020 [citado julio de 2021]. Disponible en: https://pipelinereview.com/index.php/2020012873644/Vaccines/Clover-Initiates-Development-of-Recombinant-Subunit-Trimer-Vaccine-for-Wuhan-Coronavirus-2019-nCoV.html 9. Janssen Vaccines & Prevention B.V. A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants [Internet]. ClinicalTrials.gov; 2017 [citado julio de 2021]. Disponible en: https://clinicaltrials.gov/ct2/show/NCT02543567Chen WH, Du L, Chag SM, Ma C, Tricoche N, Tao X, et al. Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Hum Vaccin Immunother. 2014;10(3):648-58. doi: 10.4161/hv.27464 11. Coleman CM, Liu YV, Mu H, Taylor JK, Massare M, Flyer DC, et al. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014;32(26):3169–74. https://doi.org/10.1016/j.vaccine.2014.04.016 12. Ministerio de Salud y Protección Social de Colombia. Plan de vacunación nacional contra COVID-19 [Internet]. 2021. Disponible en: https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspxDíaz Pinzón JE. Estimación de la prevalencia del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):99–102. https://doi.org/10.31260/RepertMedCir.01217372.1115Díaz Pinzón JE. Análisis de los resultados del contagio del COVID-19 respecto a su distribución geográfica en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):60–64. https://doi.org/10.31260/RepertMedCir.01217372.1082Díaz Pinzón JE. Dinámica y relación del contagio del COVID-19 después de iniciado el plan de vacunación contra el SARS-COV-2 en Colombia. Repert Med Cir. 2021;30(Núm. Supl.1):41–45. https://doi.org/10.31260/RepertMedCir.01217372.1227https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1750https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1751https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1752https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1767https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1280/1753: Vol. 30 Suplemento 2021Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2637https://repositorio.fucsalud.edu.co/bitstreams/e5a95254-6995-4d6f-b9a1-390d5aef280a/downloada0cddd0c99eaecf4ba717f11759abf4fMD51001/3084oai:repositorio.fucsalud.edu.co:001/30842024-02-02 13:11:08.057https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Repertorio de Medicina y Cirugía - 2021metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Cobertura de vacunación contra COVID-19 por esquema en Colombia

Publicaciones similares